A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
NCT06660654
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Metastatic Solid Tumors
Interventions
DRUG:
Raludotatug deruxtecan
Sponsor
Daiichi Sankyo
Collaborators
[object Object]